Syngene International Ltd. · SYNGENE
Every Syngene International Ltd. result whose ten-session window has closed, judged against the last read made before it. Sector index NIFTY HEALTHCARE INDEX. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
25results judged
1read right
1read wrong
4flat / no call
19unread
32%beat the market
-2.3%avg vs market, 10d
5.7%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| neutral | 3 | 0 | 0 | 3 | — | -15.4% | |
| unfavourable | 3 | 1 | 1 | 1 | 50% | +1.6% | |
| unread | 19 | 0 | 0 | 0 | — | -0.9% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
25 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 29 Jul Q1FY27 | unfavourable | right | -6.8% | -3.1% | -3.7% | -8% | no figures |
|
› |
| 29 Apr Q4FY26 | unfavourable | wrong | +10.5% | +5.1% | +7.3% | +5% | no figures |
|
› |
| 22 Jan Q3FY26 | neutral | neutral | -17.4% | -23.1% | -25.4% | -6% | no figures |
|
› |
| 5 Nov Q2FY26 | neutral | neutral | -4.7% | -1.8% | -4.2% | -3% | no figures |
|
› |
| 23 Jul Q1FY26 | unfavourable | neutral | +0.1% | -1.1% | +1.4% | +3% | no figures |
|
› |
| 23 Apr Q4FY25 | neutral | neutral | -15.9% | -18.0% | -16.7% | +11% | no figures |
|
› |
| 23 Jan Q3FY25 | — | unread | -9.6% | -12.1% | -13.6% | -6% | no figures |
|
› |
| 23 Oct Q2FY25 | — | unread | +4.5% | +9.2% | +10.1% | -10% | no figures |
|
› |
| 25 Jul Q1FY25 | — | unread | +5.0% | +12.8% | +14.0% | +5% | no figures |
|
› |
| 25 Apr Q4FY24 | — | unread | -0.3% | -3.5% | -1.4% | +1% | no figures |
|
› |
| 26 Jan Q3FY24 | — | unread | +4.6% | +8.0% | +6.7% | -2% | no figures |
|
› |
| 18 Oct Q2FY24 | — | unread | -2.5% | -4.6% | -2.4% | -9% | no figures |
|
› |
| 26 Jul Q1FY24 | — | unread | +8.2% | +7.0% | +8.2% | +3% | no figures |
|
› |
| 27 Apr Q4FY23 | — | unread | +6.9% | +7.6% | +4.9% | +12% | no figures |
|
› |
| 24 Jan Q3FY23 | — | unread | -2.5% | -1.7% | -0.5% | +0% | no figures |
|
› |
| 20 Oct Q2FY23 | — | unread | -1.8% | +5.5% | +2.0% | +4% | no figures |
|
› |
| 20 Jul Q1FY23 | — | unread | -5.3% | -5.7% | -10.9% | +14% | no figures |
|
› |
| 28 Apr Q4FY22 | — | unread | +1.5% | -14.7% | -7.3% | +7% | no figures |
|
› |
| 20 Jan Q3FY22 | — | unread | -4.4% | -5.5% | -2.5% | +2% | no figures |
|
› |
| 21 Oct Q2FY22 | — | unread | -5.9% | -8.1% | -7.5% | -4% | no figures |
|
› |
| 21 Jul Q1FY22 | — | unread | -3.6% | -5.4% | -9.6% | +10% | no figures |
|
› |
| 28 Apr Q4FY21 | — | unread | -9.0% | -6.9% | -5.7% | +12% | no figures |
|
› |
| 21 Jan Q3FY21 | — | unread | -3.9% | -4.8% | -8.4% | +2% | no figures |
|
› |
| 22 Oct Q2FY21 | — | unread | -3.2% | -0.7% | -2.3% | +22% | no figures |
|
› |
| 21 Jul Q1FY21 | — | unread | +3.3% | +8.6% | +9.2% | +16% | no figures |
|
› |